Impact of the use of an endorectal coil for 3 T prostate MRI on image quality and cancer detection rate
暂无分享,去创建一个
Thomas Kahn | Harald Busse | Michael Moche | Jens-Uwe Stolzenburg | Nicolas Linder | Alexander Schaudinn | Nikita Garnov | Gregor Thörmer | M. Moche | H. Busse | L. Horn | J. Stolzenburg | T. Kahn | D. Minh | G. Thörmer | N. Garnov | Roman Ganzer | N. Linder | Martin Reiss-Zimmermann | M. Reiss-Zimmermann | Lars-Christian Horn | Josephin Gawlitza | Do Hoang Minh | R. Ganzer | A. Schaudinn | Josephin Gawlitza
[1] Derya Yakar,et al. Initial Results of 3-Dimensional 1H-Magnetic Resonance Spectroscopic Imaging in the Localization of Prostate Cancer at 3 Tesla: Should We Use an Endorectal Coil? , 2011, Investigative radiology.
[2] C. Catalano,et al. Conventional imaging and multiparametric magnetic resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[3] T. Scheenen,et al. Prostate cancer: local staging at 3-T endorectal MR imaging--early experience. , 2006, Radiology.
[4] M. Knopp,et al. Performance comparison of 1.5-T endorectal coil MRI with 3.0-T nonendorectal coil MRI in patients with prostate cancer. , 2015, Academic radiology.
[5] T. Scheenen,et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. , 2007, Radiology.
[6] P. Choyke,et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.
[7] Namkug Kim,et al. Apparent diffusion coefficient: Prostate cancer versus noncancerous tissue according to anatomical region , 2008, Journal of magnetic resonance imaging : JMRI.
[8] Baris Turkbey,et al. Comparison of endorectal coil and nonendorectal coil T2W and diffusion‐weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole‐mount histopathology , 2014, Journal of magnetic resonance imaging : JMRI.
[9] A. Prando. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume , 2009 .
[10] P. Carroll,et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.
[11] C. Kim,et al. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.
[12] Jelle O. Barentsz,et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.
[13] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[14] Baris Turkbey,et al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? , 2011, Radiology.
[15] Leslie H. Sobin,et al. Comprar TNM Classification of Malignant Tumours, 7th Edition | C. Wittekind | 9781444332414 | Wiley , 2009 .
[16] Thomas Hambrock,et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.
[17] B. Carey,et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.
[18] Thomas Hambrock,et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.
[19] Jason A Koutcher,et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.
[20] B. Nicolas Bloch,et al. 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1). , 2004, Academic radiology.
[21] M. Moche,et al. Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values , 2012, European Radiology.
[22] T. Metens,et al. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? , 2012, European Radiology.
[23] Bum Soo Kim,et al. Comparison of Pelvic Phased-Array versus Endorectal Coil Magnetic Resonance Imaging at 3 Tesla for Local Staging of Prostate Cancer , 2012, Yonsei medical journal.
[24] A. Evans,et al. Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[25] A. D'Amico,et al. Guideline for the management of clinically localized prostate cancer: 2007 update. , 2007, The Journal of urology.
[26] A. Villers,et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.
[27] Thomas Hambrock,et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.
[28] M. Sumura,et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer , 2008, Acta radiologica.